Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data

Breast

Volumn 28, Issue , 2016, Pages 60-66

  Seigneurin, Arnaud ^a,b   Labarère, José ^a,b   François, Olivier ^b   Exbrayat, Catherine ^c   Dupouy, Maylis ^b   Filippi, Marc ^b   Colonna, Marc ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UNIV GRENOBLE ALPES   (France)

^c Off Departemental Lutte Contre L   (France)

Author keywords

Breast cancer; Cancer screening; Epidemiology; Modelling

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CALIBRATION; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SCREENING; CARCINOMA IN SITU; CAUSE OF DEATH; DIAGNOSTIC ERROR; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OVERDIAGNOSIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; SIMULATION; TUMOR INVASION; UNCERTAINTY; ADVERSE EFFECTS; BAYES THEOREM; BREAST CARCINOMA IN SITU; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COMPUTER SIMULATION; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; FALSE POSITIVE RESULT; FRANCE; HEALTH SERVICE; INCIDENCE; MIDDLE AGED; MORTALITY; RADIOTHERAPY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNNECESSARY PROCEDURE;

AGED; BAYES THEOREM; BREAST CARCINOMA IN SITU; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COMPUTER SIMULATION; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; FRANCE; HUMANS; INCIDENCE; LYMPH NODE EXCISION; MAMMOGRAPHY; MASTECTOMY, SEGMENTAL; MEDICAL OVERUSE; MIDDLE AGED; MODELS, STATISTICAL; RADIOTHERAPY; UNNECESSARY PROCEDURES;

EID: 84969802019     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2016.04.013     Document Type: Article

References (23)

1. Gøtzsche P.C., Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011, 1:CD001877. 10.1002/14651858.CD001877.pub4.
2. Pace L.E., Keating N.L. A systematic assessment of benefits and risks to guide breast cancer screening decisions. J Am Med Assoc 2014, 311(13):1327-1335. 10.1001/jama.2014.1398.
3. Marmot M.G., Altman D.G., Cameron D.A., Dewar J.A., Thompson S.G., Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer 2013, 108(11):2205-2240. 10.1038/bjc.2013.177.
4. Puliti D., Duffy S.W., Miccinesi G., de Koning H., Lynge E., Zappa M., et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 2012, 19(Suppl. 1):42-56. 10.1258/jms.2012.012082.
5. Suhrke P., Mæhlen J., Schlichting E., Jørgensen K.J., Gøtzsche P.C., Zahl P.-H. Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data. Br Med J 2011, 343:d4692.
6. Paci E., Duffy S.W. Overdiagnosis and overtreatment of breast cancer: overdiagnosis and overtreatment in service screening. Breast Cancer Res 2005, 7(6):266-270. 10.1186/bcr1339.
7. Berry D.A., Inoue L., Shen Y., Venier J., Cohen D., Bondy M., et al. Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach. J Natl Cancer Inst Monogr 2006, 36:30-36. 10.1093/jncimonographs/lgj006.
8. Seigneurin A., François O., Labarère J., Oudeville P., Monlong J., Colonna M. Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data. Br Med J 2011, 343:d7017.
9. Sobin L., Gospodarowics M., Wittekind C. The TNM classification of malignant tumours 2009, 7th ed.
10. Bender R., Augustin T., Blettner M. Generating survival times to simulate cox proportional hazards models. Stat Med 2005, 24(11):1713-1723. 10.1002/sim.2059.
11. Beaumont M.A., Zhang W., Balding D.J. Approximate Bayesian computation in population genetics. Genetics 2002, 162(4):2025-2035.
12. Blum M.G., François O. Non-linear regression models for approximate Bayesian computation. Stat Comput 2010, 20(1):63-73.
13. Csilléry K., François O., Blum M.G. abc: an R package for approximate Bayesian computation (ABC). Methods Ecol Evol 2012, 3(3):475-479.
14. Nederend J., Duijm L.E.M., Louwman M.W.J., Groenewoud J.H., Donkers-van Rossum A.B., Voogd A.C. Impact of transition from analog screening mammography to digital screening mammography on screening outcome in The Netherlands: a population-based study. Ann Oncol Off J Eur Soc Med Oncol ESMO 2012, 23(12):3098-3103. 10.1093/annonc/mds146.
15. Bleyer A., Welch H.G. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012, 367(21):1998-2005. 10.1056/NEJMoa1206809.
16. Seigneurin A., Labarère J., Duffy S.W., Colonna M. Overdiagnosis associated with breast cancer screening: a simulation study to compare lead-time adjustment methods. Cancer Epidemiol 2015, 39(6):1128-1135. 10.1016/j.canep.2015.08.013.
17. Paci E., Miccinesi G., Puliti D., Baldazzi P., De Lisi V., Falcini F., et al. Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy. Breast Cancer Res 2006, 8(6):R68. 10.1186/bcr1625.
18. Puliti D., Miccinesi G., Zappa M., Manneschi G., Crocetti E., Paci E. Balancing harms and benefits of service mammography screening programs: a cohort study. Breast Cancer Res 2012, 14(1):R9. 10.1186/bcr3090.
19. Paci E., Duffy S.W., Giorgi D., Zappa M., Crocetti E., Vezzosi V., et al. Are breast cancer screening programmes increasing rates of mastectomy? Observational study. Br Med J 2002, 325(7361):418.
20. Biesheuvel C., Barratt A., Howard K., Houssami N., Irwig L. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol 2007, 8(12):1129-1138. 10.1016/S1470-2045(07)70380-7.
21. Joe B.N., Sickles E.A. The evolution of breast imaging: past to present. Radiology 2014, 273(2 Suppl.):S23-S44. 10.1148/radiol.14141233.
22. Carter J.L., Coletti R.J., Harris R.P. Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. Br Med J 2015, 350:g7773.
23. Welch H.G., Black W.C. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find?. Ann Intern Med 1997, 127(11):1023-1028.